Inhibition of MicroRNA-494 Reduces Carotid Artery Atherosclerotic Lesion Development and Increases Plaque Stability von Wezel, A, Welten, S.M.J, Razawy, W

Volltext

Inhibition of MicroRNA-494 Reduces Carotid Artery Atherosclerotic Lesion Development and Increases Plaque Stability von Wezel, A, Welten, S.M.J, Razawy, W

Volltext

Experimental Arthritis Mouse Models Driven by Adaptive and/or Innate Inflammation von Razawy, W., Alves, C. H., Molendijk, M., Asmawidjaja, P. S., Mus, A. M. C., Lubberts, E.

Volltext

14q32 microrna inhibition reduces atherosclerotic lesion formation, increases plaque stability and lowers cholesterol levels von Wezel, A, Welten, S, Razawy, W, Lagraauw, M, de Vries, M, Kandimalla, E, Kuiper, J, Quax, P, Bot, I, Nossent, Y

Volltext

A3.08 Exploring the collagen induced arthritis model for arthralgia von Molendijk, M, Mus, AMC, Asmawidjaja, PS, Alves, CHF, Razawy, W, Lubberts, E

Volltext

A2.25 Vitamin D induces a TR1-like phenotype in human CCR6+ T cells and promotes their migration to an inflammatory environment von Dankers, W, van Hamburg, JP, Davelaar, N, Asmawidjaja, PS, Wen, K, Razawy, W, Molendijk, M, Van Leeuwen, JPTM, Colin, EM, Lubberts, E

Volltext

A2.31 Immunisation with type II collagen (CII) alters the IL-23 receptor expression profile compared to naïve conditions von Razawy, W, Alves, CH, Asmawidjaja, PS, Mus, AMC, Molendijk, M, Dankers, W, Oukka, M, Kuchroo, VK, Lubberts, E

Volltext

A6.321,25(OH)2D3 suppresses the pro-inflammatory TH17-RASF feedback loop via IL-4-dependent and -independent mechanisms von Dankers, W, van Hamburg, JP, Razawy, W, Davelaar, N, Mus, AMC, Asmawidjaja, P S, JPTM, van Leeuwen, Colin, E M, Lubberts, E

Volltext

A6.32 1,25(OH)2D3 suppresses the pro-inflammatory TH17-RASF feedback loop via IL-4-dependent and –independent mechanisms von Dankers, W, van Hamburg, JP, Razawy, W, Davelaar, N, Mus, AMC, Asmawidjaja, PS, JPTM, van Leeuwen, Colin, EM, Lubberts, E

Volltext

Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study von van de Donk, Niels W C J, Minnema, Monique C, van der Holt, Bronno, Schjesvold, Fredrik, Wu, Ka Lung, Broijl, Annemiek, Roeloffzen, Wilfried W H, Gadisseur, Alain, Pietrantuono, Giuseppe, Pour, Ludek, van der Velden, Vincent H J, Lund, Thomas, Offidani, Massimo, Grasso, Mariella, Giaccone, Luisa, Razawy, Wida, Tacchetti, Paola, Mancuso, Katia, Silkjaer, Trine, Caers, Jo, Zweegman, Sonja, Hájek, Roman, Benjamin, Reuben, Vangsted, Annette Juul, Boccadoro, Mario, Gay, Francesca, Sonneveld, Pieter, Musto, Pellegrino

Volltext